44 related articles for article (PubMed ID: 11309554)
1. Gastrin-releasing peptide is a potent vasodilator in humans.
Clive S; Jodrell D; Webb D
Clin Pharmacol Ther; 2001 Apr; 69(4):252-9. PubMed ID: 11309554
[TBL] [Abstract][Full Text] [Related]
2. Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide.
Affolter JT; McKee SP; Helmy A; Jones CR; Newby DE; Webb DJ
Clin Pharmacol Ther; 2003 Jul; 74(1):9-16. PubMed ID: 12844130
[TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
5. Direct biochemical evidence for eNOS stimulation by bradykinin in the human forearm vasculature.
Lauer T; Kleinbongard P; Preik M; Rauch BH; Deussen A; Feelisch M; Strauer BE; Kelm M
Basic Res Cardiol; 2003 Mar; 98(2):84-9. PubMed ID: 12607129
[TBL] [Abstract][Full Text] [Related]
6. The contribution of nitric oxide and vasodilatory prostanoids to bradykinin-mediated vasodilation in Type 1 diabetes.
Wotherspoon F; Browne DL; Meeking DR; Allard SE; Munday LJ; Shaw KM; Cummings MH
Diabet Med; 2005 Jun; 22(6):697-702. PubMed ID: 15910619
[TBL] [Abstract][Full Text] [Related]
7. (6R)-5,6,7,8-tetrahydro-L-biopterin and its stereoisomer prevent ischemia reperfusion injury in human forearm.
Mayahi L; Heales S; Owen D; Casas JP; Harris J; MacAllister RJ; Hingorani AD
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1334-9. PubMed ID: 17413035
[TBL] [Abstract][Full Text] [Related]
8. The functional consequence of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in young healthy volunteers.
Godfrey V; Chan SL; Cassidy A; Butler R; Choy A; Fardon T; Struthers A; Lang C
Cardiovasc Drug Rev; 2007; 25(3):280-8. PubMed ID: 17919260
[TBL] [Abstract][Full Text] [Related]
9. Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.
Clive S; Webb DJ; MacLellan A; Young A; Byrne B; Robson L; Smyth JF; Jodrell DI
Clin Cancer Res; 2001 Oct; 7(10):3071-8. PubMed ID: 11595697
[TBL] [Abstract][Full Text] [Related]
10. [Endothelial-derived nitric oxide mediates the peripheral vasodilatory effects of amrinone in humans].
Sakane T; Ishibashi Y; Shimada T; Inoue S; Sugamori T; Hirano Y; Takahashi N; Ohata S; Asanuma T; Kato H; Yoshitomi H; Sano K; Murakami Y; Murakami R
J Cardiol; 1999 Jan; 33(1):13-9. PubMed ID: 10028457
[TBL] [Abstract][Full Text] [Related]
11. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
[TBL] [Abstract][Full Text] [Related]
12. [Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].
Benacerraf S; Carville C; Sediame S; Belhassen L; Adnot S; Dubois-Randé JL
Arch Mal Coeur Vaiss; 2000 Sep; 93(9):1103-8. PubMed ID: 11055001
[TBL] [Abstract][Full Text] [Related]
13. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
[TBL] [Abstract][Full Text] [Related]
14. The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men.
Dishy V; Sofowora G; Harris PA; Kandcer M; Zhan F; Wood AJ; Stein CM
Clin Pharmacol Ther; 2001 Sep; 70(3):270-9. PubMed ID: 11557915
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
[TBL] [Abstract][Full Text] [Related]
16. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal.
Calver A; Collier J; Moncada S; Vallance P
J Hypertens; 1992 Sep; 10(9):1025-31. PubMed ID: 1328361
[TBL] [Abstract][Full Text] [Related]
17. C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism.
Johansson BL; Wahren J; Pernow J
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E864-70. PubMed ID: 12799312
[TBL] [Abstract][Full Text] [Related]
18. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
[TBL] [Abstract][Full Text] [Related]
19. Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.
Newby DE; Sciberras DG; Mendel CM; Gertz BJ; Boon NA; Webb DJ
Br J Clin Pharmacol; 1997 May; 43(5):493-9. PubMed ID: 9159564
[TBL] [Abstract][Full Text] [Related]
20. Peripheral endothelial dysfunction in normal pressure glaucoma.
Henry E; Newby DE; Webb DJ; O'Brien C
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1710-4. PubMed ID: 10393040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
